Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-02-01

Clinical Trial Update: Role of Anabolic Steroids on Intensive Care Unit-Acquired Weakness [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update discusses a Phase 2/Phase 3 study evaluating the role of anabolic steroids in ICU-acquired weakness among critically ill patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anabolic steroids (anabolic steroids)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Critical Illness Polyneuropathies | Phase 2, Phase 3 | Status: UNKNOWN